• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
LIU Tai,ZENG Peipei,ZHANG Qingping.Meta analysis of Yangxueqingnao Granule in the treatment of vascular cognitive dysfunction[J].Journal Of Pharmaceutical Research,2016,35(1):49-52[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 4665times   Download 3994次 QR Code for this article
Scan with your phone!
养血清脑颗粒治疗血管性认知功能障碍疗效的Meta分析
刘泰,曾佩佩,张青萍
Font:Larger+|Default|Smaller-
(广西中医药大学第一附属医院,广西 南宁 530023)
摘要:
目的 评价养血清脑颗粒治疗血管性认知功能障碍的疗效。方法 通过计算机检索工具检索、手工检索,全面搜集养血清脑颗粒治疗血管性认知功能障碍的随机对照实验,按Cochrane协作网发布的RevMan 5.2软件对多个研究结果的总体效应进行Meta分析。结果 共纳入8个实验(579例患者),其中8个实验均对MMSE进行评分,显示养血清脑颗粒提高MMSE评分优于对照组[WMD=2.47,95%CI(1.57,3.37)];4个实验对患者HDS进行评分,提示养血清脑颗粒提高HDS评分优于对照组[WMD=4.80,95%CI(3.94,5.67)];4个实验对患者ADL进行评分,显示养血清脑颗粒提高ADL评分优于对照组[WMD=-4.43,95%CI(-5.75,-3.12)];4个实验对患者有效率进行评定,提示养血清脑颗粒的疗效优于对照组[OR=2.87,95%CI(1.67,4.94)];结论 养血清脑颗粒治疗血管性认知功能障碍有效。
关键词:  养血清脑颗粒  血管性认知功能障碍  血管性痴呆  Meta分析
DOI:
基金项目:广西医疗卫生适宜技术研究与开发课题(No.S201410-01)
Meta analysis of Yangxueqingnao Granule in the treatment of vascular cognitive dysfunction
LIU Tai,ZENG Peipei,ZHANG Qingping
(The First Affiliated Hospital of Guangxi traditional Chinese Medicine University,Nanning 530023,China)
Abstract:
Objective To evaluate the therapeutic effect of Yangxue Qingnao Granule on vascular cognitive impairment.Methods The randomized controlled trials of Yangxue Qingnao Granule in treating vascular cognitive impairment was collected by computer retrieval tools and manual retrieval,extract data and Meta-analysis was analyzed with Revman 5.2 software released by Cochrane.Results 8 experiments were included (579 patients),all experiments were carried out on the MMSE score,results displayed that Yangxue Qingnao Granule improving MMSE scores was better than the control group [WMD=2.47,95%CI (1.57,3.37)];4 experiments were carried out on the HDS scores,which displayed that Yangxue Qingnao Granule improving HDS was better than the control group [WMD=4.80,95%CI(3.94,5.67)];4 experimental were carried out on the HDL scores,results displayed that Yangxue Qingnao Granule improving ADL scores was better than the control group [WMD=-4.43,95%CI (-5.75,-3.12)];4 experimental was evaluated on efficiency, which indicated that the effect of Yangxue Qingnao granule was better than the control group [OR=2.87, 95%CI (1.67,4.94)];Conclusion Yangxue Qingnao Granule was efficacious on treating vascular cognitive impairment.
Key words:  Yangxue Qingnao Granule  Vascular cognitive impairment  Vascular dementia  Meta analysis
Today's Visits:445    Total Visits:2383128
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.